#GivingTuesday Gratitude
ECAN thanks everyone who donated or raised funds to support our medical research campaign on #GivingTuesday! You and the rest [...]
ECAN Advocates Convince Congress to Include Esophageal Cancer in a Multi-Million Dollar Research Fund
For the second year in a row, thousands of ECAN advocates made their voices heard and convinced lawmakers in the [...]
First Patient Dosed in Phase 3 Trial Testing Tyvyt as First-line Therapy for Esophageal Cancer
First Esophageal Cancer patient is dosed in Phase 3 clinical trial using immune checkpoint inhibitor Tyvyt (sintilimab injection), in [...]
Esophageal Cancer Genome
ECAN’s President and CEO Mindy Mintz Mordecai recently had the opportunity to interview Dr. Adam Bass, co-chair of the [...]